[Effect of vasodilator agents in chronic heart failure].
D006332:Cardiomegaly / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D010646:Phentolamine / Q000627:therapeutic use*; D010919:Placebos; D011224:Prazosin / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010919:Placebos; D011799:Quinazolines; D014665:Vasodilator Agents; D007548:Isosorbide Dinitrate; D011224:Prazosin; D010646:Phentolamine
Einflu beta von Vasodilatantien auf die chronische Herzinsuffizienz.